. . . . . . . . . . . . . . . . . . . . "TextLocation" . "Results" . "kin(p(HGNC:PRKACA)) => p(HGNC:GSK3B,pmod(P,S,9))" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "Consistent with this in vivo activity, PKAc enzyme efficiently phosphorylated GSK-3α\nand -β at serine 21 and 9 in vitro (Fig. 4B), which was blocked by addition\nof the PKA peptide inhibitor (PKI) (26). Similar results were obtained when immunoprecipitated\nGSK- 3α, immunoprecipitatedHA-GSK-3β, purified GSK-3α, or recombinant\nGSK-3β was used as substrate (Fig. 4B)." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:34.731+02:00"^^ . . .